NCT02306681View on ClinicalTrials.gov

A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes

CompletedOBSERVATIONAL
Enrollment

7,315

Participants

Timeline

Start Date

October 30, 2014

Primary Completion Date

May 14, 2015

Study Completion Date

May 14, 2015

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
OTHER

No treatment given

This study comprises of a two-part SAQ (Self-Assessment Questionnaire). Paired responses to SAQ1 and SAQ2 will be used to estimate the differences in the frequency of hypoglycaemic episodes between the retrospective and prospective periods.

Trial Locations (8)

1

Novo Nordisk Investigational Site, Bogotá

2

Novo Nordisk Investigational Site, Pretoria

1000

Novo Nordisk Investigational Site, Dhaka

1605

Novo Nordisk Investigational Site, Manila

21499

Novo Nordisk Investigational Site, Ajman

169608

Novo Nordisk Investigational Site, Singapore

Unknown

Novo Nordisk Investigational Site, Cairo

06100

Novo Nordisk Investigational Site, Ankara

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY